heltzen investor CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference Oct 23, 2025 4:31:14 PM
press release investor eXoZymes provides second quarter 2025 update at 5PM EST today Aug 12, 2025 4:28:01 PM
press release investor eXoZymes to host second quarter 2025 update on Tuesday August 12, 2025, at 5PM EST Aug 7, 2025 4:15:00 PM
press release investor nutraceuticals video science eXoZymes details biomanufacturing breakthrough: 4 grams of NCT with over 99% purity Jul 29, 2025 7:57:00 AM
press release investor nutraceuticals video science eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months Jul 22, 2025 4:04:00 PM
press release investor nutraceuticals medicine science eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing Jun 26, 2025 4:04:00 PM
investor press clippings video Slack Capital interview: Chris Marlett, Chairman of the Board May 22, 2025 5:23:00 PM
heltzen press release investor press clippings Podcast: eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on 'Grow Everything' May 16, 2025 9:09:00 AM
.jpg?width=1024&height=1024&name=Damien+NCT(thumbnail).jpg)
.jpg?width=1024&height=1024&name=Paul+NCT(HD).jpg)
.png?width=1024&height=1024&name=ExoZymes%20-%20MDB%20Capital%20(1).png)
.png?width=1024&height=1024&name=_ExoZymes%20-%20Commercial%20(1).png)
